In Vitro effects of tamoxifen on equine neutrophils.

The researchers have examined the effects of tamoxifen, a non-steroidal estrogen receptor modulator, on certain functionalities of equine neutrophils, the first line of defense against microorganisms in the immune system. According to their study, tamoxifen influences the chemotaxis, respiratory burst production and phagocytosis of these cells.

Objective of the Study

• The researchers sought to evaluate the influence of tamoxifen on the functional capabilities of equine peripheral blood neutrophils, specifically focusing on chemotaxis, respiratory burst production and phagocytosis.

Methods

• The procedure involved performing chemotaxis, respiratory burst production, and phagocytosis assays on neutrophils. These cells were isolated from the peripheral blood samples taken from ten healthy horses.

Results

• The scientists discovered that cells stimulated by Interleukin-8 (IL-8), which is a chemotactic factor, reduced their chemotactic index when they were treated with tamoxifen. This indicates that the movement of these cells was affected by the presence of this drug.
• The production of respiratory burst, an important aspect of the neutrophil’s function, was also found to be reduced after being treated with tamoxifen. This implies that the capacity of these cells to rapidly generate reactive oxygen species is affected by tamoxifen.

Conclusion

• The researchers concluded that tamoxifen has a direct impact on equine peripheral blood neutrophils. They emphasized the need for more in-depth in vivo and in vitro investigations to completely comprehend tamoxifen’s actions on neutrophils. This would aid in determining whether tamoxifen could be used as a potential treatment for disorders like allergic asthma in both humans and horses.